Potential Antineoplastic Structural Variations of Uracil Mustard (Uramustine) Retaining Cytotoxic Activity and Drug-likeness Suitable for Oral Administration
Journal of Cancer and Tumor International · pp. 50–58 · Published 27 Apr 2015
10.9734/JCTI/2015/17780Abstract
Aims: To present 12 new variants of uracil mustard having drug-like properties and cytotoxic functional group, by utilizing uracil mustard (uramustine) as a lead compound. Utilize rigorous substructure and similarity of a molecular scaffold to determine drug like variants. Physicochemical properties determined indicate the variants have favorable drug-likeness. Study Design: Conduct molecular database search utilizing features of substructure and similarity based upon uracil mustard. Place and Duration of Study: Department of Chemistry, Medicinal Chemistry Study Section, University of Nebraska at Omaha, Omaha Nebraska between January 2015 to March 2015. Methodology: Uracil mustard consists of the pyrimidine derivative uracil, having the bifunctional nitrogen mustard cytotoxic moiety covalently bonded onto the ring. A systematic search, utilizing substructure component and similarity, within an in-silico database search successfully determined 12 variants. Rigorous criteria for drug-likeness was implemented to screen potential candidates that included the application of the Rule of 5. In addition, maintaining the cytotoxic moiety of nitrogen mustard was crucial. Results: A total of 12 variants of uracil mustard was identified after an extensive molecular database search using rigorous criteria. All 12 variants, and including uracil mustard, showed zero violations of the Rule of 5, thereby indicating favorable drug-likeness. Values of polar surface area for all compounds at less than 80 Angstroms2 are suitable for central nervous system penetration. Polar surface area, number of atoms, and Log P for all compounds increased as the molecular weight increases. Structure substituents include nitrogen mustard groups, hydroxyl, alkyl and carbonyl moieties. Cluster analysis discerned greatest similarity among members of this group. Conclusion: Applying rigorous search criteria within a molecular data base, for comparison and reject, successfully identified 12 variants of uracil mustard that show favorable drug-likeness in addition to cytotoxic capability. The design of new antitumor agents is important for increasing efficacy of the clinical treatment of cancer.
References (21)
- 1 Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1 [DOI]
- 2 Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties [DOI]
- 3 Sample Criteria for Testing Outlying Observations [DOI]
- 4 Medicinal chemistry; a biochemical approach [DOI]
- 5 Fundamentals of Medicinal Chemistry
- 6 Uracil mustard revisited [DOI]
- 7 Design of Ciprofloxacin Derivatives that Inhibit Growth of Methicillin Resistant Staphylococcus aureus (MRSA) and Methicillin Susceptible Staphylococcus aureus (MSSA) [DOI]
- 8 The antitumor activity of 5-bis-2'-chlorethyl)-aminouracil (uracil mustard).
- 9 5-BIS-(2-CHLOROETHYL)-AMINOURACIL, A NEW ANTITUMOR AGENT [DOI]
- 10 An application of 3D-QSAR to the analysis of the sequence specificity of DNA alkylation by uracil mustard [DOI]
- 11 Therapeutic Spectrum of Uracil-Mustard, A New Oral Antitumor Drug [DOI]
- 12 Uracil Mustard, a New Alkylating Agent for Oral Administration in the Management of Patients with Leukemia and Lymphoma [DOI]
- 13 Uracil Mustard in the Treatment of Thrombocytosis [DOI]
- 14 Therapeutic approaches to non-Hodgkin’s lymphoma in the elderly patient [DOI]
- 15 Uracil mustard and 5-fluorouracil combination chemotherapy: a historic record.
- 16 Single, combined and sequential use of uracil mustard and prednisone in the treatment of lymphoreticular tumors.
- 17 Effect of uracil mustard in chronic lymphatic leukemia and malignant lymphoma.
- 18 Effect of uracil mustard in malignant lymphoma and chronic lymphatic leukemia.
- 19 Uracil mustard therapy in acute leukemia in children.
- 20 Derivatives of Cephalothin that Inhibit Ampicillin Resistant Escherichia Coli [DOI]
- 21 Two Novel Alkylating Structural Analogues of Chloramphenicol Suitable for Topical Treatment of Dermal Neoplasms [DOI]
Cited by 8
Maryam Mohamadi, Asadollah Hassankhani, S. Yousef Ebrahimipour · International Journal of Biological Macromolecules · 2017
Zheng‐Bao Qin, Kun Ni, Li Wang · Chinese Journal of Chemistry · 2024
Samar A. El-Kalyoubi, Ehab S. Taher, Tarek S. Ibrahim · Pharmaceuticals · 2022
Showing 3 of 8 known citations — external sources report more than can currently be individually listed.
Related research
- Does Pain Adversely Affect the Quality of Life in Hospitalized Cancer Patients? — shares topic coverage
- Complementary Medicine Intervention in Breast Cancer Patients with Pain — shares topic coverage
- Use of Performance Status Score for Cytotoxic Chemotherapy among Surgeons in a Tertiary Hospital, Southern Nigeria — shares topic coverage
- Breast Self Examination and Cancer Awareness among Female Staff in Federal Medical Center, Yenagoa, Bayelsa State (Knowledge and Practice) — shares topic coverage
- Assessment of Cancer Risk from Fluorscopic Bile Duct Examinations at Sanjiwani Hospital, Gianyar — shares topic coverage
Article metrics
Real usage data collected on this platform.
28
Page views
0
PDF downloads
4
Outbound clicks
8
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.